Interpace Diagnostics: Up on Blue Cross Blue Shield contract

Interpace Biosciences

31/07/2019 18:14

** Cancer diagnostics co's shares  IDXG.O  rise as much as
4.8% to 91 cents
    ** Interpace Diagnostics Group signs contract with health
insurer Blue Cross Blue Shield of Michigan so that two of its
thyroid cancer tests are covered for 6 mln members  urn:newsml:reuters.com:*:nGNXc8LX5V
    ** Co signed a similar agreement with Blue Shield of
California on Monday  urn:newsml:reuters.com:*:nGNX1phQBc
    ** Including session's gains, stock is up ~14% YTD

 (Reporting by Shivani Singh)
 ((ShivaniSingh1@thomsonreuters.com;))